Initiative promotes adoption of value-based care models in community pharmacy settings.
By adding an adjuvant to an existing vaccine treatment, it’s possible to optimize the body’s response to the presence of a virus.
Developing innovative solutions for women with depression, accounting for differences in gender and sex, are critically important
Further evidence-based antidepressant treatments are needed for children and adolescents with depression.
Wildfire smoke is a considerable contributor to air pollution, with wildfire smoke exposure consistently associated with respiratory morbidity including lung cancer risk.
Until social distancing measures are phased out, store owners who want to make a difference in independent pharmacy can and should leverage technology to connect with legislators virtually.
Resources with pertinent information are essential in motivating individuals to comply with vaccine recommendations.
Research shows that telemedicine bridges gaps in healthcare access despite party affiliations.
The prevalence of annual alcohol consumption is highest in full-time college students 1 to 4 years after high school.
Mavacamten improves functional capacity and symptoms in adults with New York Heart Association class II-III obstructive HCM.
Anesthetic gases and meter dose inhalers, how we use our antibiotics, how we use our resources for infection prevention and control, and how we use plastic and food in our hospitals all add up.
How can e-prescribing improve the workflow between pharmacists and their veterinarian colleagues?
Do no harm, even though your patient might.
The COVID-19 pandemic has exposed the cracks in health system pharmacy. Here’s how the workforce can adapt.
Nerivio received clearance in January 2021 for use in acute migraine.
This past year has seen several important new drug approvals and labeling updates for children. Here is what you should know.
GLP-1 receptor agonists, used to manage diabetes, are now being used for
obesity in children and adolescents.
Black patients reported associating negative emotions with experiences of racial discrimination long after the experience concluded, raising concerns about long-term health outcomes.
The drug’s approval was based on the results of 3 clinical trials.
Sometimes, breaches in information are the result of a simple mistake. How can those be avoided?
By 2029, the global market for cannabinoid-based pharmaceuticals will reach $50 billion.
The pill, Paxlovid, showed an 88% decrease in hospitalization and death for those taking it 5 days after experiencing COVID-19 symptoms.
2 Commerce Drive Cranbury, NJ 08512